Cleared Traditional

K792653 - SENTRY

K792653 is an FDA 510(k) clearance for SENTRY, manufactured by Automated Screening Devices. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 9-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1980
Decision
9d
Days
Class 2
Risk

K792653 is an FDA 510(k) clearance for the SENTRY. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Automated Screening Devices (Mchenry, US). The FDA issued a Cleared decision on January 4, 1980 after a review of 9 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K792653

510(k) Number K792653 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 1979
Decision Date January 04, 1980
Days to Decision 9 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
116d faster than avg
Panel avg: 125d · This submission: 9d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 1225
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K792653.
MICRONTA BP-1 ELECTRONIC B/P TESTER
K800225 · Tandy Corp. · Mar 1980
NIASTAT
K800066 · Invivo Research Labs, Inc. · Feb 1980
DINAMAP RESEARCH MONITOR 1245
K800025 · Applied Medical Research · Feb 1980
MODEL 1978 PRESSUROMETER III AMBULATORY
K792075 · Del Mar Avionics · Dec 1979
VITA-STAT MODEL 900-D
K792193 · Vita-Stat Medical Services, Inc. · Nov 1979
VITA-STAT MODEL 900-S
K792194 · Vita-Stat Medical Services, Inc. · Nov 1979